Complexes between C1q and C3 or C4: Novel and specific markers for classical complement pathway activation

Journal of Immunological Methods

Volumn 298, Issue 1-2, 2005, Pages 35-45

  Wouters, Diana ^a,e   Wiessenberg, Hans D ^a   Hart, Margreet ^a   Bruins, Peter ^b   Voskuyl, Alexandre ^c   Daha, Mohamed R ^d   Hack, C Erik ^a,c  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

Author keywords

Activation products; Complement; In vitro; In vivo; Inflammation

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN G; LECTIN; MONOCLONAL ANTIBODY; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; RHEUMATOID ARTHRITIS;

EID: 17444388866     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.12.018     Document Type: Article

References (35)

1. G.J. Arlaud, V. Rossi, N.M. Thielens, C. Gaboriaud, B. Bersch, and J.F. Hernandez Structural and functional studies on C1r and C1s: new insights into the mechanisms involved in C1 activity and assembly Immunobiology 199 1998 303
2. P. Bruins, V.H. te, A.P. Yazdanbakhsh, P.G. Jansen, F.W. van Hardevelt, E.M. de Beaumont, C.R. Wildevuur, L. Eijsman, A. Trouwborst, and C.E. Hack Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542
3. M. Budayova-Spano, M. Lacroix, N.M. Thielens, G.J. Arlaud, J.C. Fontecilla-Camps, and C. Gaboriaud The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex EMBO J. 21 2002 231
4. M.G. Colomb, G.J. Arlaud, and C.L. Villiers Activation of C1 Philos. Trans. R. Soc. Lond., B Biol. Sci. 306 1984 283
5. B.J. de Smet, J.P. de Boer, J. Agterberg, G. Rigter, W.K. Bleeker, and C.E. Hack Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats Blood 81 1993 56
6. P.L. Ey, G.J. Russell-Jones, and C.R. Jenkin Isotypes of mouse IgG-I. evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement Mol. Immunol. 17 1980 699
7. M. Gadjeva, A.W. Dodds, A. Taniguchi-Sidle, A.C. Willis, D.E. Isenman, and S.K. Law The covalent binding reaction of complement component C3 J. Immunol. 161 1998 985
8. M. Gadjeva, S. Thiel, and J.C. Jensenius The mannan-binding-lectin pathway of the innate immune response Curr. Opin. Immunol. 13 2001 74
9. E.N. Guan, W.H. Burgess, S.L. Robinson, E.B. Goodman, K.J. McTigue, and A.J. Tenner Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis J. Biol. Chem. 266 1991 20345
10. C.E. Hack, A.J. Hannema, A.J. Eerenberg-Belmer, T.A. Out, and R.C. Aalberse A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo J. Immunol. 127 1981 1450
11. C.E. Hack, J. Paardekooper, R.J. Smeenk, J. Abbink, A.J. Eerenberg, and J.H. Nuijens Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies J. Immunol. 141 1988 1602
12. R. Hoekzema, M. Martens, M.C. Brouwer, and C.E. Hack The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q Mol. Immunol. 25 1988 485
13. M. Kirschfink Targeting complement in therapy Immunol. Rev. 180 2001 177
14. L.B. Klickstein, S.F. Barbashov, T. Liu, R.M. Jack, and A. Nicholson-Weller Complement receptor type 1 (CR1, CD35) is a receptor for C1q Immunity 7 1997 345
15. S.C. Makrides Therapeutic inhibition of the complement system Pharmacol. Rev. 50 1998 59
16. E.T. Molenaar, A.E. Voskuyl, A. Familian, G.J. van Mierlo, B.A. Dijkmans, and C.E. Hack Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein Arthritis Rheum. 44 2001 997
17. F.D.J. Moore Therapeutic regulation of the complement system in acute injury states Adv. Immunol. 56 1994 267
18. R.R. Nepomuceno, and A.J. Tenner C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets J. Immunol. 160 1998 1929
19. S.V. Petersen, S. Thiel, L. Jensen, R. Steffensen, and J.C. Jensenius An assay for the mannan-binding lectin pathway of complement activation J. Immunol. Methods 257 2001 107
20. S.V. Petersen, S. Thiel, and J.C. Jensenius The mannan-binding lectin pathway of complement activation: biology and disease association Mol. Immunol. 38 2001 133
21. Y. Sato, R. Sato, H. Watanabe, A. Kogure, K. Watanabe, T. Nishimaki, R. Kasukawa, M. Kuraya, and T. Fujita Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors Ann. Rheum. Dis. 52 1993 795
22. B.F. Tack, R.A. Harrison, J. Janatova, M.L. Thomas, and J.W. Prahl Evidence for presence of an internal thiolester bond in third component of human complement Proc. Natl. Acad. Sci. U. S. A. 77 1980 5764
23. S.W. Tas, L.B. Klickstein, S.F. Barbashov, and A. Nicholson-Weller C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion J. Immunol. 163 1999 5056
24. A.J. Tenner, and N.R. Cooper Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells J. Immunol. 125 1980 1658
25. A.J. Tenner, and N.R. Cooper Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component J. Immunol. 128 1982 2547
26. A.J. Tenner, P.H. Lesavre, and N.R. Cooper Purification and radiolabeling of human C1q J. Immunol. 127 1981 648
27. N.M. Thielens, B. Bersch, J.F. Hernandez, and G.J. Arlaud Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex Immunopharmacology 42 1999 3
28. A.P. van Dam, and C.E. Hack Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement Immunology 61 1987 105
29. I. von Zabern, and I. Gigli Conformational changes in complement component C4 induced by activation, treatment with amines, chaotropes, or freezing-thawing, detectable by radioiodination using lactoperoxidase J. Immunol. 128 1982 1439
30. T. Vorup-Jensen, S.V. Petersen, A.G. Hansen, K. Poulsen, W. Schwaeble, R.B. Sim, K.B. Reid, S.J. Davis, S. Thiel, and J.C. Jensenius Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2 J. Immunol. 165 2000 2093
31. M.J. Walport Complement. first of two parts N. Engl. J. Med. 344 2001 1058
32. M.J. Walport Complement. Second of two parts N. Engl. J. Med. 344 2001 1140
33. G.J. Wolbink, J. Bollen, J.W. Baars, R.J. ten Berge, A.J. Swaak, J. Paardekooper, and C.E. Hack Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway J. Immunol. Methods 163 1993 67
34. R.J. Ziccardi Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition J. Immunol. 136 1986 3378
35. R.J. Ziccardi Studies on the mechanism of C3b inhibition of immune complex induced C1 activation Mol. Immunol. 25 1988 1339